LAPATINIB

LAPATINIB (11251E)

lapatinib 250 mg tablet, 70
11251E
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 9360)

Indication: Metastatic (Stage IV) HER2 positive breast cancer
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 140 # of repeats: 2 DPMQ: $2,210.82 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Tykerb

LAPATINIB (9148L)

lapatinib 250 mg tablet, 70
9148L
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Metastatic (Stage IV) HER2 positive breast cancer
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 140 # of repeats: 2 DPMQ: $2,210.82 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Tykerb